HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use DOPAMINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOPAMINE HYDROCHLORIDE INJECTION. DOPAMINE HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 INDICATIONS AND USAGEDopamine HCl Injection is a catecholamine indicated to improve hemodynamic status in patients in shock. (1) DOSAGE AND ADMINISTRATIONCorrect hypovolemia, acidosis, and hypoxia prior to use. (2.1) Administer in a large vein with an infusion pump preferably in an intensive care setting. (2.1) Recommended starting dosage in adults and pediatric patients is 2 to 5 mcg/kg/minute as a continuous intravenous infusion. Titrate in 5 to 10 mcg/kg/minute increments based on hemodynamic response and tolerability, up to not more than 50 mcg/kg/minute. (2.2) See the Full Prescribing Information for important preparation instructions and drug incompatibilities. (2.1,2.3) DOSAGE FORMS AND STRENGTHSThe following strengths of Dopamine HCL, USP, are supplied in single-dose vials: (3)
CONTRAINDICATIONSDopamine is contraindicated in patients with pheochromocytoma. (4) WARNINGS AND PRECAUTIONS
ADVERSE REACTIONSThe most common adverse reaction is localized vasoconstriction due to extravasation. (6) To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS
See 17 for PATIENT COUNSELING INFORMATION. Revised: 9/2023 |
HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use DOPAMINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOPAMINE HYDROCHLORIDE INJECTION. DOPAMINE HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 INDICATIONS AND USAGEDopamine HCl Injection is a catecholamine indicated to improve hemodynamic status in patients in shock. (1) DOSAGE AND ADMINISTRATIONCorrect hypovolemia, acidosis, and hypoxia prior to use. (2.1) Administer in a large vein with an infusion pump preferably in an intensive care setting. (2.1) Recommended starting dosage in adults and pediatric patients is 2 to 5 mcg/kg/minute as a continuous intravenous infusion. Titrate in 5 to 10 mcg/kg/minute increments based on hemodynamic response and tolerability, up to not more than 50 mcg/kg/minute. (2.2) See the Full Prescribing Information for important preparation instructions and drug incompatibilities. (2.1,2.3) DOSAGE FORMS AND STRENGTHSThe following strengths of Dopamine HCL, USP, are supplied in single-dose vials: (3)
CONTRAINDICATIONSDopamine is contraindicated in patients with pheochromocytoma. (4) WARNINGS AND PRECAUTIONS
ADVERSE REACTIONSThe most common adverse reaction is localized vasoconstriction due to extravasation. (6) To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS
See 17 for PATIENT COUNSELING INFORMATION. Revised: 9/2023 |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.